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Abstract
Pseudoachondroplasia (PSACH) is an autosomal dominant skeletal dysplasia caused by mutations in cartilage oligomeric
matrix protein (COMP) and characterised by short limbed dwarfism and early onset osteoarthritis. Mouse models of PSACH
show variable retention of mutant COMP in the ER of chondrocytes, however, in each case a different stress pathway is
activated and the underlying disease mechanisms remain largely unknown. T585M COMP mutant mice are a model of
moderate PSACH and demonstrate a mild ER stress response. Although mutant COMP is not retained in significant
quantities within the ER of chondrocytes, both BiP and the pro-apoptotic ER stress-related transcription factor CHOP are
mildly elevated, whilst bcl-2 levels are decreased, resulting in increased and spatially dysregulated chondrocyte apoptosis.
To determine whether the abnormal chondrocyte apoptosis observed in the growth plate of mutant mice is CHOP-
mediated, we bred T585M COMP mutant mice with CHOP-null mice to homozygosity, and analysed the resulting
phenotype. Although abnormal apoptosis was alleviated in the resting zone following CHOP deletion, the mutant growth
plates were generally more disorganised. Furthermore, the bone lengths of COMP mutant CHOP null mice were significantly
shorter at 9 weeks of age when compared to the COMP mutant mice, including a significant difference in the skull length.
Overall, these data demonstrate that CHOP-mediated apoptosis is an early event in the pathobiology of PSACH and suggest
that the lack of CHOP, in conjunction with a COMP mutation, may lead to aggravation of the skeletal phenotype via a
potentially synergistic effect on endochondral ossification.
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Introduction
Pseudoachondroplasia (PSACH) is an autosomal dominant
skeletal dysplasia resulting from mutations in cartilage oligomeric
matrix protein (COMP), a large pentameric glycoprotein present
in cartilage, bone, skeletal muscle, tendon and ligament [1,2].
PSACH manifests with short-limbed dwarfism, joint laxity and
early onset osteoarthritis [3,4]. COMP is thought to act as a
bridging molecule in the cartilage extracellular matrix (ECM) and
interacts with a number of other structural ECMmolecules such as
matrilin-3 [5], type IX collagen [6], type II collagen [7] and
aggrecan [8] as well as signalling receptors such as integrins [9,10].
PSACH-causing mutations in COMP cluster in two distinct
regions of the molecule, the thrombospondin type 3 (T3-COMP)
repeats and the C-terminal (CTD-COMP) globular domain [11].
Type 3 repeat mutations account for the majority PSACH cases
and are all believed to result in misfolding of the mutant protein
and its retention in the endoplasmic reticulum (ER) [12,13].
Analysis of the growth plate in a targeted mouse model of
T3-COMP PSACH with the common p.D469del mutation
demonstrated increased and dysregulated chondrocyte apoptosis
and decreased proliferation. However, there was no transcription-
al evidence of a conventional ER stress response in mutant
chondrocytes [14] and an aggregated protein response (APR) was
proposed as an alternative mechanism.
In contrast, the CTD-COMP mutations, which account for a
smaller percentage of PSACH often allow the secretion of the
mutant protein [15,16]. In a T585M CTD-COMP targeted
mouse model the mild stress response leads to decreased
chondrocyte proliferation and a dysregulated increase in apoptosis
[16]. The mild ER stress is characterised by a transcriptional
increase in several ER markers including BiP and the pro-
apoptotic transcription factor CHOP. We therefore hypothesised
that the abnormal chondrocyte apoptosis in the T585M COMP
mouse growth plate was CHOP-mediated as a direct result of the
ER stress caused by the folding and trafficking of mutant T585M
COMP protein [16].
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CHOP [also known as DDIT3 (DNA Damage Inducible
Transcript 3) and GADD153 (Growth Arrest and DNA-Damage
inducible gene)] is an ER stress inducible leucine zipper
transcription factor associated with ER stress related apoptosis
[17–19]. CHOP can be activated via the PERK and ATF6
unfolded protein response (UPR) pathways and acts to decrease
the levels of the anti-apoptotic protein bcl-2, which subsequently
renders the cells more susceptible to programmed cell death
[20,21]. Mouse embryonic fibroblasts derived from mice that are
null for CHOP are resistant to ER stress induced apoptosis [22]
and CHOP deficiency promotes cell survival in an ER stress
related model of type 2 diabetes [23]. CHOP can also be
upregulated in oxidative stress conditions independently of ER
stress [24]. CHOP can form heterodimers with other molecules
such as C/EBPb and LAP and act as a transdominant negative
inhibitor of C/EBPb signalling [17], it may also modulate
transcriptional activity of other genes via its interactions with
fos/jun and atf proteins [25,26].
To determine whether the increase in chondrocyte apoptosis in
the CTD-COMP mouse model of mild PSACH was CHOP
mediated we crossed this mouse model with CHOP null mice and
analysed the resulting phenotype. In this paper we confirm that
CHOP plays an important role in bone biology, but more
importantly we demonstrate that the dysregulation of apoptosis in
the proliferative zone of growth plates in T585M COMP mutant
mice is not directly mediated by CHOP.
Materials and Methods
Generation of mouse lines
CHOP null mice (B6.129S-Ddit3tm1Dron/J) were obtained
from the Jackson Laboratory and crossed with homozygous
T585M COMP knock-in mice [16] to obtain mice heterozygous
for both mutations. These mice were then recrossed with the
COMP mutant mice to obtain mice that were homozygous for the
T585M COMP mutation and either wild type or knock-out for
CHOP. C57BL6/J mice were obtained from Jackson Laboratory.
All experiments were approved by the University of Manchester
Animal Ethical Review Group and performed in compliance with
the Scientific Procedures Act of 1986 and the relevant Home
Office (under PPL 40/2884) and Institutional regulations govern-
ing animal breeding and handling.
Bone measurements
Mice of the relevant genotypes (10 per age per genotype) were
sacrificed at 3, 6 and 9 weeks of age and X-rayed using a Faxitron
MX-20 X-ray machine. A direct phenotypic comparison between
mice with different genetic backgrounds may not be biologically
relevant due to differences in the basal levels of the quantitative
disease parameters [27]. Therefore, genetically matched controls
were used for each of the mouse models in this study and in all
cases data generated from mutant mice were compared to the
relevant controls. Bone lengths were determined using Growbase
software (Certus Technology Ltd) and one-way ANOVA and t-test
were used for statistical analysis. Hip angles were measured as
described previously [16] (Figure S1).
Histology and immunohistochemistry
Mice were sacrificed at 3 weeks of age and hindlimbs were
dissected from surrounding tissues. These were fixed in either 10%
neutral buffered formaldehyde (PFA; histology) or 95% ethanol
5% acetic acid (immunohistochemistry) for 48 h in 4uC. Limbs
were then decalcified in 20% EDTA pH 7.4 over 2 weeks, wax
embedded and cut into 6 mm sections. Haematoxylin/eosin (H&E)
staining was used to visualise the general morphology of the tissue
using the automated Thermo Shandon stainer.
Immunohistochemistry and BrdU labelling (a real-time mea-
surement of cell proliferation) were performed as described
previously [16]. BrdU labelled cells were counted and presented
as a percentage of all (DAPI stained) cells in the proliferative zone
with One-Way ANOVA used for statistical analysis of these data
(Figure S2).
TUNEL assay
TUNEL assay was performed on PFA fixed sections of 3 week
old limbs using the Promega Dead-End Fluorimetric Kit as
described previously [16]. The samples were unmasked using citric
buffer boil [16] instead of proteinase K unmasking, which can
generate false positives [28]. Positive cells labelled with FITC were
counted and presented as a percentage of all (DAPI stained) cells
in selected zones of the growth plate. One-Way ANOVA was used
for statistical analysis of the data.
Western blotting and mass spectrometry analysis using
xiphoid cartilage
The xiphoid process is a well-established model in the
proteomic and transcriptomic analysis of chondrodysplasias. It
contains a rudimentary growth plate (Figure S3 and S4), which we
have previously shown accurately recapitulates the disease
pathology seen in mutant tibia, and it can be cleanly and easily
dissected [29]. A representative image of the growth plate found in
the xiphoid process has been included in Figure S3. Xiphoid
processes were extracted from mice of the different genotypes at 3
weeks of age, snap frozen in liquid nitrogen and dismembranated
in 100 ml dH2O, either separately, or in pooled samples (3 mice
per sample). Total protein content in the samples was measured
using the BCA assay (Thermo Scientific) and the samples were run
for 5 minutes at 200 V into 10% BisTris precast gel (Novex). Gels
were stained for 15 min with InstantBlue Coomassie-based stain
(Expedeon) and rinsed with distilled water. Gel slices were then
excised and washed in acetonitrile for 5 min, dried in a vacuum
centrifuge for 15 min and reduced for 1 h (56uC) in 10 mM DTT,
25 mM NH4HCO3. Samples were cooled to room temperature
and DTT was removed by centrifugation.The proteins within the
gel were alkylated with 55 mM iodoacetamide in 25 mM
NH4HCO3 for 45 min. The samples were then centrifuged and
washed with 25 mM NH4HCO3 for 10 min, then washed in
acetonitrile and dried in a vacuum centrifuge for 15 min. Proteins
were digested using 12.5 ng/ml trypsin solution (Sigma) in 25 mM
NH4HCO3 overnight at 37uC. Digested peptides were extracted
with 20 mM NH4HCO3 for 20 min, centrifuged, then extracted
twice with 5% formic acid in 50% acetonitrile. The extractions
were pooled and concentrated in a vacuum centrifuge before a
MALDI-TOF analysis. Data were interrogated using Mascot
version 2.2 (Matrix Science, UK) against the UniProt database
(version 2011-05) with taxonomy of Mus musculus and the following
search parameters selected: fragment tolerance: 0.6 Da; parent
tolerance: 0.5 Da; fixed modifications allowed: +57 on C
(carbamidomethyl), +16 on M (oxidation); max missed cleavages:
1. Mascot search results were validated using Scaffold version
3.3.1 (Proteome Software, Portland, USA) to assign confidence
values to peptide/protein matches, where Peptide/Protein Proph-
et algorithm confidence values of 0.7 and 0.99 were used
respectively. Identified proteins were defined as having a number
of matched peptide spectra $2, and the unweighted spectral count
was used as a measure of quantification. These parameters
constrained the protein false discovery rate (FDR) to #0.2% in all
analyses. Four biological replicates were used. The number of
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spectra identified for each protein were compared between
COMP m/m CHOP +/+ and COMP m/m CHOP 2/2
genotypes using the beta-binomial test in R (version 2.14.2,
BetaBinomial package) [30]. A P-value,0.05 was considered
significant.
Results
Long bone growth in CHOP null mice is normal but their
heads are shorter by 9 weeks of age
CHOP null mice were previously described as skeletally normal
based on X-ray analysis performed from 1 to 12 months of age
[31]. We performed a detailed analysis of radiographs from
CHOP null mice at 3, 6 and 9 weeks of age and confirmed that
there were no significant differences in the lengths of the tibia,
pelvis and femur between wild type and CHOP null mice
(Figure 1A and Table S1). Intramembraneous ossification (assessed
by measuring the inner canthal distance) was also not affected by
the deletion of CHOP. In contrast, the length of the skull, which is
formed through a combination of endochondral and intramem-
branous ossification, was 4.7% shorter in CHOP null mice at 9
weeks of age when compared to the wild type controls (n = 10)
(Figure 1B and Table S1). This unexpected finding suggests a role
for CHOP in skull morphogenesis.
Figure 1. Bone measurements in mice lacking CHOP. A) Long bone measurements (cm) of wild type and CHOP null mice at 3, 6 and 9 weeks of
age confirming that deletion of CHOP had no effect on the long bone formation (n = 10). B) Head measurements (cm) in wild type and CHOP null
mice demonstrating shorter skulls in CHOP null mice at 9 weeks of age (n = 10; One Way ANOVA). Key: ICD= inner canthal distance; CHOP+/+=wild
type, CHOP2/2= knock-out. Error bars show standard error of the mean (SEM); * P,0.05.
doi:10.1371/journal.pone.0085145.g001
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Tibial growth plates from CHOP null mice have a regular
columnar organisation of chondrocytes at 3 weeks of age
and a normal ECM
We analysed the morphology and composition of the tibial
growth plates from 3-week-old wild type and CHOP null mice to
determine the role of CHOP in endochondral ossification. H&E
staining confirmed that there were no obvious differences in the
overall morphology of both the wild type and CHOP null growth
plates, which had regular columnar arrangements of chondrocytes
in the proliferative zone with comparable thickness of the resting,
proliferative and hypertrophic zones (Figure 2A, Figure S5 and not
shown). The level of COMP staining was comparable between
genotypes suggesting normal ECM organisation in the growth
plates of CHOP null mice (Figure 2B).
An enriched C57BL6/J genetic background increases the
severity of chondrodysplasia in the T585M COMP mice
The CHOP null mice were originally generated on a C57BL6/J
genetic background, whilst the background of our original T585M
COMP mouse line was a combination of several different genetic
strains, primarily 129Sv and CBA. Since our breeding strategy for
generating double mutant mice [CHOP2/2/COMPm/m] led to
an enrichment of the C57BL6/J background in the T585M
COMP model, we first analysed the effect of this change in genetic
background on the phenotype of the T585M COMP model prior
to studying the CHOP2/2/COMPm/m mice. To achieve this we
crossed the T585M COMP mutant mice onto a C57BL6/J
genetic background for 5 back-crossed generations, which resulted
in approximately 97% enrichment of the C57BL6/J background
in the T585M COMP mouse line [COMPm/mC57+].
Interestingly, the growth plates of [COMPm/mC57+] mice were
more disorganised when compared with age-matched wild type
Figure 2. Histochemical analysis of growth plate cartilage. A)
Haematoxylin and eosin staining of wild type and CHOP null growth
plates at 3 weeks of age showing normal columnar organisation of
chondrocytes in the growth plates of both genotypes and delineating
the resting (RZ), proliferating (PZ) and hypertrophic (HZ) zones of the
growth plate. B) Immunohistochemistry for COMP showing the normal
distribution of COMP in wild type and CHOP null growth plate at 3
weeks of age. The negative control was generated using the secondary
antibody only. Key: RZ = resting zone; PZ =proliferative zone; HZ=hy-
pertrophic zone; CHOP+/+=wild type, CHOP2/2= knock-out. Scale bar
for all images is 100 mm.
doi:10.1371/journal.pone.0085145.g002
Figure 3. Histochemical and immunohistochemical analysis of
growth plate cartilage. A) Haematoxylin and eosin staining of
C57BL6/J enriched wild type (+/+ C57+) and T585M COMP mutant (m/m
C57+) cartilage growth plates at 3 weeks of age showing further
disorganisation and more hypocellular areas (red circles) in the m/m
C57+ growth plates. B) Immunohistochemistry for COMP at 3 weeks of
age showing abnormal columnar organisation of the growth plates in
the mutant mice with areas of hypocellularity (red circles) and the
retention of COMP in the T585M COMP mutant (COMPm/mC57+)
hypertrophic zone (red arrowheads) on the C57BL6/J enriched genetic
background. Positive COMP staining is brown with green nuclear
counterstain. The negative control was generated using the secondary
antibody only. Key: +/+=wild type mice (mixed background); +/+
C57+=wild type mice (enriched C57 background); m/m= T585M COMP
mutant mice (mixed background); m/m C57+= T585M COMP mutant
mice (enriched C57 background). Scale bar in all images is 100 mm.
doi:10.1371/journal.pone.0085145.g003
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Figure 4. BrdU and TUNEL labelling of growth plate cartilage. A) The relative proportion of BrdU positive cells in wild type and T585M COMP
mutant growth plates compared to the corresponding C57BL6/J enriched mice (n = 3; One Way ANOVA). This analysis demonstrated a further
decrease in chondrocyte proliferation at 3 weeks of age due to the change in genetic background. B) Representative images of TUNEL staining in
C57BL6/J enriched wild type and COMP mutant cartilage growth plates at 3 weeks of age. Green staining (yellow arrowheads) identifies TUNEL
positive (apoptotic) cells against a DAPI (blue) nuclear counter stain. C) Quantification of the TUNEL staining in wild type and mutant growth plates at
3 weeks of age (n=3; OneWay ANOVA) showing further dysregulation of apoptosis. Key: COMP+/+=wild typemice (mixed background); COMP+/+C57+=wild
type mice (enriched C57 background); COMPm/m=T585M COMP mutant mice (mixed background); COMPm/m C57+=T585M COMP mutant mice (enriched
Role of CHOP in the Aetiology of Mild PSACH
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[COMP+/+C57+] controls and the original T585M COMP
mutant mice (Figure 3A and [16]). In addition to a general
disruption to the normal localisation of several ECM molecules
(not shown) similar to that which has previously been reported for
the T585M COMP mutant mice and manifests as reduced
staining for COMP, matrilin-3 and type IX collagen in the
acellular gaps between the mutant chondrocyte columns [16], we
now noted that mutant COMP was retained to some extent in the
chondrocytes within the hypertrophic zone of 3-week-old
[COMPm/mC57+] mice (Figure 3B, red arrowheads).
Furthermore, although a direct comparison between the
different genetic backgrounds was not possible, we nevertheless
found that chondrocyte proliferation between the mutant growth
plates (and their appropriate wild type controls) was mildly
decreased on the C57BL6/J background (i.e. a decrease of 24% in
T585M COMP compared to 29% in [COMPm/m C57+] thus
representing a 17% reduction) (Figure 4A and Table S4). Finally,
chondrocyte apoptosis was more dysregulated with a further
increase in apoptosis in the resting and proliferating zones, but
with a slight decrease in the hypertrophic zone, of growth plates
from mice with an enriched C57BL6/J background (Figure 4 B
and C).
CHOP2/2/COMPm/m mice have abnormal growth plates
with more pronounced spatial disorganisation
To determine the role of CHOP in the pathobiology of CTD-
COMP-related PSACH, we crossed the T585M COMP mice with
the CHOP null mice and analysed the resulting phenotype. By 3
weeks of age the tibial growth plates of [CHOP2/2/COMPm/m]
mice appeared further disorganised compared to [CHOP+/+/
COMPm/m] mice with more pronounced spaces between the
columns of chondrocytes within the proliferative zone, and also a
distinct hypocellular appearance to the hypertrophic zone
(Figure 5A). This disorganisation to the hypertrophic zone had
not been previously observed in the T585M COMP mutant mice,
or in the [COMPm/m C57+] mice, and therefore appeared to be
the direct result of CHOP ablation.
The organisation of the extracellular matrix is not
affected by CHOP ablation in T585M COMP mutant mice
Immunohistochemistry for COMP, matrilin-3 and type IX
collagen was performed on the cartilage growth plates from 3 week
old [CHOP2/2/COMPm/m] and [CHOP+/+/COMPm/m] mice
(Figure 5B and not shown). COMP staining in the ECM was
depleted in a similar fashion to that previously reported for the
T585M COMP mice [16]. Moreover, a proportion of mutant
COMP was retained within the chondrocytes of the hypertrophic
zone of both [CHOP2/2/COMPm/m] and [CHOP+/+/COMPm/
m] mice (Figure 5B), which may be directly due to the enriched
C57BL6/J genetic background, rather than deletion of CHOP
itself. Staining for matrilin-3 and type IX collagen followed the
same distribution as mutant COMP (not shown) and there appeared
to be no differences in the distribution of these ECM components
between the [CHOP2/2/COMPm/m] and [CHOP+/+/COMPm/m]
growth plate cartilages.
The deletion of CHOP alleviates abnormal chondrocyte
apoptosis in the resting zone of T585M COMP mutant
growth plates but does not affect proliferation
TUNEL assay was performed on the growth plates of 3-week-
old mice to determine whether the deletion of CHOP would
ablate the abnormal chondrocyte apoptosis observed in the
T585M COMP mutant growth plates. At 3 weeks of age the
relative levels of apoptosis in the resting zone of [CHOP2/2/
COMPm/m] mice were decreased by 2.8-fold (p,0.001) when
compared to [CHOP+/+/COMPm/m] mice. However, apoptosis
was not improved in the proliferative or hypertrophic zones of the
growth plate (Figure 6A and Table S4). Furthermore, the decrease
in apoptosis in the resting zone of [CHOP2/2/COMPm/m] mice
resulted in a trend towards a greater number of chondrocytes in
C57 background). Error bars show standard error of the mean (SEM); * P,0.05, **P,0.01, *** P,0.001.
doi:10.1371/journal.pone.0085145.g004
Figure 5. Histochemical and immunohistochemical analysis of
growth plate cartilage. A) Haematoxylin and eosin staining of T585M
COMP mutant and either CHOP wild type [CHOP+/+COMPm/m] or CHOP
null [CHOP2/2COMPm/m] growth plates at 3 weeks of age. Areas of
hypocellularity localised to the lower hypertrophic zone (red circles) are
seen in [CHOP2/2COMPm/m] cartilage compared to [CHOP+/+COMPm/m]
controls. B) Immunohistochemistry for COMP showing abnormal
columnar organisation of the growth plate in the COMP mutant CHOP
null mice [CHOP2/2COMPm/m] with areas of hypocellularity (yellow
circles) in the hypertrophic zone at 3 weeks of age. Mutant COMP was
also retained in chondrocytes of the hypertrophic zone of both [CHOP+/
+COMPm/m] and [CHOP2/2COMPm/m] due to the enriched C57BL6/J
background in this model (see yellow arrows). Positive staining for COMP is
brown with a green nuclear counterstain. The negative control was
generated using a secondary antibody only. Key: CHOP+/+COMPm/m=CHOP
wild type and T585M COMP mutation (homozygous); CHOP2/2
COMPm/m=CHOP null and T585M COMP mutation (homozygous). Scale
bar in all images is 100 mm.
doi:10.1371/journal.pone.0085145.g005
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each growth plate zone (Figure 6B; 26% p,0.01 in the resting
zone; 13% p=0.08 (n.s.) in the proliferative zone; 28% p,0.01 in
the hypertrophic zone). The increased number of cells per zone
did not have an impact on the growth plate thickness at 3 weeks of
age (Figure S5). We also noticed a trend towards a higher absolute
number of TUNEL positive cells in the terminal hypertrophic
zone of [CHOP2/2/COMPm/m] mice (Figure 6C; 22% p=0.06).
The relative level of the important anti-apoptotic protein bcl-2 was
increased by 35% in [CHOP2/2/COMPm/m] mice (Figure 7A
and B), which may reflect the decrease in apoptosis observed in the
resting zone of [CHOP2/2/COMPm/m] mice. In addition the
relative level of the key UPR chaperone protein BiP was increased
by 40% following the deletion of CHOP in T585M COMP mice
(Figure 7B and Table S3).
BrdU labelling was performed at 3 weeks of age to determine
the relative levels of chondrocyte proliferation in the growth plates
of [CHOP2/2/COMPm/m] and [CHOP+/+/COMPm/m] mice.
Chondrocyte proliferation was comparable between the two
genotypes (Figure 7C and Table S4; 10.25%60.47 and
9.62%60.38 respectively) indicating that CHOP signalling had
no effect on the abnormal proliferation levels in the original
T585M COMP mice.
Deletion of CHOP leads to a decrease in the levels of
several bone maturation markers
Mass spectrometry was performed on the proteins extracted
from homogenized 3 week old xiphoid cartilage from T585M
COMP mutant mice either wild type or null for CHOP (Table 1).
Relative total amounts of protein at the start of the experiment
were taken into account and spectral counting showed significant
changes in the levels of several proteins involved in bone
homeostasis and maturation including decorin, perilipin and
thrombospondin-1. Fibrillin, a protein important for osteoblast
maturation and fibromodulin and HPLN1, both of which are
expressed in the hypertrophic zone of the cartilage and in bone,
were also decreased in the xiphoid of [CHOP2/2/COMPm/m]
cartilage. Finally, we detected a decrease in the relative levels of
nebulin, which may also be involved in cartilage/bone biology.
The long bones and skulls are shorter in [CHOP2/2/
COMPm/m] mice
[CHOP2/2/COMPm/m] and [CHOP+/+/COMPm/m] mice
were radiographed at 3, 6 and 9 weeks of age to determine the
effect of CHOP ablation on bone growth in T585M COMP
mutant mice. At 6 weeks of age the femurs in [CHOP2/2/
COMPm/m] mice were 5.5% shorter than in the control mice and
by 9 weeks this difference had reached 15.4% (Figure 8B and
Table S2; p,0.05 and p,0.001 respectively). In addition, by 9
weeks of age the skulls (8% p,0.05) and tibia (3.8% p,0.01) were
also shorter in [CHOP2/2/COMPm/m] mice (Figure 8A and B),
suggesting a potential synergistic effect of the T585M COMP
mutation and CHOP ablation on bone growth. Interestingly a hip
dysplasia [16], measured by the angle between the ischial and the
pubic bone, was alleviated by the deletion of CHOP (6 weeks, 25%
decrease p,0.01; 9 weeks 8% decrease p,0.05; data not shown).
Discussion
Pseudoachondroplasia (PSACH) is characterised by short-
limbed dwarfism, a waddling gait and early onset osteoarthritis
[3,4]. PSACH is believed to result exclusively from mutations in
two distinct domains of cartilage oligomeric matrix protein
(COMP); the thrombospondin type 3 repeat region (T3) and the
C-terminal globular domain (CTD) [1,32,33]. In vitro analysis of
cartilage from PSACH patients with a range of different T3-
COMP mutations consistently shows enlarged rER that can have
a characteristic lamellar appearance. Following these observations
it was hypothesised that PSACH resulted from an unfolded
protein response (UPR) elicited by misfolded COMP retained in
the ER of chondrocytes [34,35].
In contrast, the pathology of CTD-COMP mutations appeared
more complex and it was demonstrated in several studies that
these mutations often allow the folding and secretion of the mutant
protein [15,36]. Nevertheless, in a gene targeted mouse model of a
specific CTD-COMP mutation (T585M), the expression and
secretion of this mutant protein resulted in dysregulated chondro-
cyte apoptosis and decreased proliferation. Moreover, the relative
levels of the anti-apoptotic protein bcl-2 were decreased and mild
ER stress was detected in mutant chondrocytes, including an
increase in the levels of the ER stress related and pro-apoptotic
transcription factor CHOP [16]. We therefore considered that
CHOP might be an important factor in the pathogenesis of
T585M-COMP induced PSACH and that the dysregulated
chondrocyte apoptosis was induced by ER stress and mediated
by CHOP. We hypothesised that crossing the T585M-COMP
mice onto CHOP null genetic background [22] would alleviate the
PSACH phenotype.
To determine the role of CHOP in T585M-COMP pathology
we crossed the T585M-COMP mice onto a CHOP null
background, but during this process we enriched the C57BL6/J
background of the original T585M-COMP mice. Genetic
background is an important consideration when performing
studies on animal models of disease and breeding mice onto
various defined strains can dramatically increase or decrease
disease severity [27,37]. In the first instance we therefore analysed
what effect such change in the genetic background would have on
the phenotypic severity in the T585M-COMP model.
We found that the PSACH phenotype on the enriched
C57BL6/J background was slightly more severe. In particular,
the columns of chondrocytes in the proliferative zone were further
disrupted and mutant COMP was also visibly retained in the
hypertrophic chondrocytes of the cartilage growth plates, thereby
resembling the more severe T3-COMP pathology as previously
reported [14]. Moreover, at 3 weeks of age the chondrocyte
apoptosis was slightly increased and proliferation was further
decreased, suggesting the influence of a background-specific
genetic modifier of disease severity.
Figure 6. TUNEL assay and cell quantification in growth plate at 3 weeks of age. A) Quantification of the TUNEL staining in T585M COMP
mutant and either CHOP wild type [CHOP+/+COMPm/m] or CHOP null [CHOP2/2COMPm/m] growth plates. This analysis shows a significant decrease in
apoptosis in the resting zone following deletion of CHOP (n = 3; One Way ANOVA). B) The average number of cells per growth plate zone showing a
significant increase in the RZ and HZ and a trend towards an increase in the PZ following deletion of CHOP (n = 3; One Way ANOVA). C) The average
number of TUNEL positive cells per growth plate zone showing a significant decrease in the RZ and a trend towards an increase in the HZ of the
[CHOP2/2COMPm/m] growth plates (n = 3; One Way ANOVA). Key: CHOP+/+COMPm/m=CHOP wild type and T585M COMP mutation (homozygous);
CHOP2/2COMPm/m=CHOP null and T585M COMP mutation (homozygous); RZ= resting zone; PZ= proliferative zone; HZ=hypertrophic zone. Error
bars show standard error of the mean (SEM); # P= 0.06, * P,0.05, ** P,0.01, *** P,0.001.
doi:10.1371/journal.pone.0085145.g006
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Figure 7. Western blot and BrdU analysis of mouse cartilage at 3 weeks of age. A) A representative image of a bcl-2 Western blot on mouse
xiphoid homogenates at 3 weeks. 4 mice per genotype (1–4); GAPDH was used as a loading control. B) Densitometry of Western blots of cartilage
homogenates from xiphoid cartilage showing an significant increase in bcl-2 and BiP protein after CHOP removal (n = 3; t-test) B) Quantification of
the relative number of BrdU positive cells in T585M COMP mutant and either CHOP wild type [CHOP+/+COMPm/m] or knock-out [CHOP2/2COMPm/m]
growth plate showing that CHOP deletion had no effect on chondrocyte proliferation (n = 3; t-test). Key: CHOP+/+COMPm/m=CHOP wild type and
T585M COMP mutation (homozygous); CHOP2/2COMPm/m=CHOP null and T585M COMP mutation (homozygous). Error bars show standard error of
the mean (SEM); * P,0.05.
doi:10.1371/journal.pone.0085145.g007
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CHOP null mice have previously been described as skeletally
normal based on full body radiographs taken between 1 and 12
months of age [31]. They have normal osteoblast numbers but
show decreased rates of trabecular bone formation and it was
hypothesised that CHOP is important for normal osteoblast
function. Furthermore, the overexpression of CHOP in an in vitro
system favours differentiation of stromal cells towards osteoblasts,
indicating an important role for CHOP in bone biology [38]. In
addition, the levels of osteocalcin and type I collagen expression
were decreased in the calvarial bones from 3 month old CHOP
null mice [31]. In this study we confirm that CHOP null mice are
overall skeletally normal and that neither endochondral nor
intramembranous ossification appears to be disrupted. However,
CHOP does appear to play a role in skull formation, as evidenced
by our X-ray measurements showing 4.7% shorter skulls in CHOP
null mice at 9 weeks of age.
CHOP null mice have correctly organised cartilage growth
plates with a typical columnar arrangement of chondrocytes
within the proliferative zone. In contrast, T585M-COMP mutant
mice present with disruption to the columnar organisation
characterised by rounded clusters of cells and spaces between
the individual columns of chondrocytes, particularly in the
proliferative zone [16]. This phenotype appeared further exacer-
bated following the deletion of CHOP such that the spaces
extended towards the hypertrophic zone and the vascular invasion
front in the growth plates of [CHOP2/2/COMPm/m] mice. The
secretion of key extracellular matrix proteins appeared similar
between genotypes suggesting that no additional disruptions to the
ECM organisation were induced by the deletion of CHOP. A
slight retention of mutant T585M-COMP in chondrocytes of the
hypertrophic zone was noted and this was not alleviated by the
deletion of CHOP.
Chondrocyte proliferation was not affected in [CHOP2/2/
COMPm/m] mice and this is in agreement with previous studies on
both CHOP-null mice and mice overexpressing CHOP in bone,
both of which did not show any difference in BrdU incorporation
in osteoblasts and suggesting that CHOP per se does not play a
significant role in cell proliferation [31,38]. Chondrocyte apoptosis
was only decreased in the resting zone of [CHOP2/2/COMPm/m]
mice suggesting that abnormal chondrocyte apoptosis in the
proliferative zone, which is hypothesised to be one of the key
factors in the disease aetiology of T585M-COMP related PSACH,
is in fact not CHOP mediated. Interestingly, the decrease in
apoptosis in the resting zone resulted in an absolute increase in the
total number of cells in the proliferative and hypertrophic zones,
and by inference, an increase in the overall number of cells
undergoing apoptosis in the hypertrophic zone. The exacerbated
growth plate pathology may therefore be a direct result of this
additional dysregulation of chondrocyte apoptosis.
Interestingly, a mild increase in CHOP was also detected in a
tetracycline-inducible transgenic mouse model of T3-COMP
PSACH [39], whereby mutant COMP protein was retained
within the ER of chondrocytes leading to an increase in apoptosis
and a short-limbed dwarfism. Furthermore, anti-apoptotic tran-
scripts (such as bcl-2 and bag3) were decreased, whereas pro-
apoptotic genes (including CHOP) were mildly increased in the
mutant growth plates, along with other oxidative stress and DNA
damage markers [39]. When CHOP was deleted in these
transgenic mice, mutant protein retention was alleviated, abnor-
mal apoptosis was decreased and chondrocyte proliferation
increased. Moreover, the authors noted a decrease in the levels
of other ER stress inducible genes suggesting a potential role of
CHOP in PSACH pathogenesis [40]. However, it is important to
note that transgenic models of disease, although appropriate for
modelling certain molecular interactions, often result in over-
expression of the mutant protein and therefore do not always
accurately model the disease pathology. Transcriptomic analysis of
the more physiologically relevant knock-in mouse model of T3-
COMP PSACH showed no increased expression of ER stress
related genes including CHOP and suggested that T3-COMP
PSACH results from a combination of oxidative stress, apoptosis
and cell cycle arrest [14].
CHOP is an early marker of stress in response to ER overload
and its expression differs between acute and mild, but prolonged,
UPR [18,41]. Furthermore, it has been recently shown that
CHOP mRNA transcripts and indeed CHOP protein itself have
short half lives in prolonged mild ER stress [41]. It is therefore
interesting to speculate that CHOP-mediated cell death in the
resting zone of [CHOP2/2/COMPm/m] mice is an initial
selection mechanism against the ER stress induced by mutant
COMP expression whereby the cells that cannot resolve the
processing of mutant protein die via ER-stress mediated apoptosis,
whilst the remainder continue to proliferate and differentiate as
normal. Conversely, in the transgenic model the overexpression of
COMP may result in ER overload and a higher more prolonged
upregulation of CHOP.
CHOP is known to signal directly to downregulate the major
anti-apoptotic protein bcl-2 [21]. In [CHOP2/2/COMPm/m]
Table 1. Mass spectrometry (LC-MS/MS) of T585M mutant and CHOP wild type [CHOP+/+/COMPm/m] or knock-out [CHOP2/2/
COMPm/m] cartilage at 3 weeks of age.
gene protein
Average spectra number
[CHOP+/+/COMPm/m]
Average spectra number
[CHOP2/2/COMPm/m] P value
chad chondroadherin 2 0 0.004 **
fmod fibromodulin 2 0 0.006 **
dcn decorin 3.25 0 0.007 **
fbn1 fibrillin-1 10 2.75 0.02 *
tsp1 thrombospondin-1 0 1.25 0.03 *
neb nebulin-1 13.25 6.25 0.04 *
hpln1 hyaluronan and proteoglycan link protein 1 2.5 0.5 0.05 *
plin1 perilipin-1 1.75 0 0.05 *
The average number of spectra are shown for each genotypes (n = 4).
doi:10.1371/journal.pone.0085145.t001
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mice the bcl-2 protein levels in cartilage were increased by 40%,
which may reflect the positive effect that the deletion of CHOP
had on apoptosis of chondrocytes in the resting zone. Moreover,
BiP levels were significantly increased in T585M-COMP mutant
chondrocytes following the deletion of CHOP. The induction of
glucose-regulated proteins including BiP (also known as Grp78)
during the mild prolonged ER stress is a late event compared to
CHOP induction [18]. Therefore, an increase in the relative levels
of BiP may be perceived as a marker of mild persistent ER stress in
[CHOP2/2/COMPm/m] chondrocytes and could be identifying
Figure 8. Head and bone measurements in COMP mutant and CHOP null mice. A) Head measurements in T585M COMP mutant and either
CHOP wild type [CHOP+/+COMPm/m] or CHOP null [CHOP2/2COMPm/m] showing shorter skulls in [CHOP2/2COMPm/m] at 9 weeks of age (n = 10; One
Way ANOVA). B) Long bone measurements in [CHOP2/2COMPm/m] mice showing a further exacerbated short limbed dwarfism following CHOP
deletion (n = 10; One Way ANOVA). Error bars represent standard error of the mean (SEM) Key: Key: CHOP+/+COMPm/m=CHOP wild type and T585M
COMP mutation (homozygous); CHOP2/2COMPm/m=CHOP null and T585M COMP mutation (homozygous); ICD= inner canthal distance. Error bars
represent standard error of the mean (SEM); * P,0.05, ** P,0.01, *** P,0.001.
doi:10.1371/journal.pone.0085145.g008
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the population of resting chondrocytes which have not died via
ER-stress mediated apoptosis. An increase in BiP is thought to
inhibit the progression of late ER stress signalling events since
more chaperone molecules are synthesised to aid in folding of the
mutant protein [18]. Plasma cells, which are a good example of
‘professional’ secretory cells, are known to customise their UPR
during differentiation and in preparation for the secretion of
immunoglobulins [41]. They adapt to the persistent mild ER stress
via a stable up-regulation of BiP and other molecular chaperones
[42]. Growth plate chondrocytes also secrete large amounts of
large complex extracellular matrix proteins; it is therefore
interesting to speculate that they might also possess a similar
ability to adapt to physiological and pathological stresses.
The further dysregulation of the cartilage growth plates of
[CHOP2/2/COMPm/m] mice may contribute to the overall
decrease in long bone length and exacerbation of the PSACH
phenotype. Moreover, the skulls of [CHOP2/2/COMPm/m] mice
were also shorter than those of T585M-COMP mice suggesting a
potential synergistic effect of mutant COMP and CHOP ablation
in bone formation. The role of CHOP in skull morphogenesis,
although beyond the scope of this study, is an interesting topic and
will be investigated further.
Overall these data suggest that the synergy between the C-
terminal COMP mutation (T585M) and a deletion of CHOP,
which leads to the exacerbated PSACH phenotype, is most likely
manifested at the bone/cartilage interphase. This is possibly due to
role of CHOP in osteoblast differentiation, which combined with
the abnormal pre-ossification cartilage template arising through
mutant COMP deposition in the cartilage ECM could in turn
influence the differentiation of osteoblasts. Moreover, mass
spectrometry of the xiphoid cartilage from 3 week old mice
revealed a decrease in the levels of proteins important for bone
maturation, in COMP mutant CHOP null mice when compared
with the COMP mutant mice alone.
The deletion of CHOP in the T585M-COMP model did not
affect the relative levels of apoptosis in the proliferative and
hypertrophic zones of the mutant growth plates, suggesting a
mechanism of cell death that was not CHOP-mediated. We have
previously shown that the ECM in the original T585M-COMP
cartilage is noticeably disrupted in the proliferative and hypertro-
phic zones, whilst cell morphology is also abnormal. We therefore
hypothesise that chondrocyte apoptosis in these zones is a
consequence of the abnormal extracellular environment, rather
than due to the processing of the mutant protein per se, and as such
may be mediated by different genetic pathways.
In summary, we have shown that CHOP plays an important
role in an early stress response in T585M-COMP related PSACH
and further confirmed a role for CHOP in bone pathobiology. We
have also shown that in the absence of CHOP the chondrocytes
can adapt during mild ER stress and that the mechanism
underlying abnormal chondrocyte apoptosis in the proliferative
zone of T585M-COMP PSACH is most likely due to an
extracellular stress induced by the abnormal architecture of the
mutant ECM. Our study therefore provides a new insight into the
role of mild ER stress in PSACH disease progression and excludes
CHOP as a potential therapeutic target in the CTD-COMP forms
of PSACH.
Supporting Information
Figure S1 Full length x-ray image of a mouse homozy-
gous for T585M mutant COMP (m/m) showing the five
bone length measurements used in this study.
(TIF)
Figure S2 A) Representative image of BrdU immunostaining
following the 2 h BrdU labelling of the cartilage growth plate in 3
week old mice. The black lines delineate the proliferative zone
where the BrdU positive cells were counted individually and
expressed as a percentage of all the cells in the zone. B) Negative
(secondary only) control. Scale bar is 100 mm.
(TIF)
Figure S3 A) Haematoxylin and eosin staining of a wild type
mouse xiphoid process from a 3 week old mice showing both the
bone and also growth plate cartilage. B) Enlarged xiphoid growth
plate section showing easily recognisable resting, proliferative and
hypertrophic zones. Key: HZ=hypertrophic zone, PZ=prolifera-
tive zone, RZ= resting zone. Scale bar 200 mm.
(TIF)
Figure S4 A) Immunostaining of a wild type mouse xiphoid
process from a 3 week old mice for the cartilage markers COMP,
matrilin-3 and type IX collagen confirming the cartilaginous tissue
in the xiphoid process. B) Immunostaining for type X collagen (a
marker of hypertrophic chondrocytes) and osteopontin (OPN; a
bone and skeletal muscle marker) in the xiphoid process at 3 weeks
of age. In all images positive staining is brown with a green nuclear
counterstain and the negative control is the secondary antibody
only. Scale bar is 200 mm.
(TIF)
Figure S5 Measurement of the growth plate thickness
from the vascular invasion front to the top of the resting
zone in [COMP m/m CHOP +/+] and [COMP m/m
CHOP 2/2] growth plates at 3 weeks of age (n=5; t-
test).
(TIF)
Table S1 Raw data for bone measurements in CHOP
wild type and CHOP null mice (n=10, One Way
ANOVA). Standard error of the mean. Key: ICD inner canthal
distance, +/+ wild type, 2/2 knockout (null). * P,0.05.
(DOCX)
Table S2 Raw data for bone measurements in COMP
m/m CHOP +/+ and COMP m/m CHOP 2/2 mice
(n=10, One Way ANOVA). Standard error of the mean. Key:
ICD inner canthal distance, +/+ wild type, 2/2 knockout (null),
m/m homozygous mutant. * P,0.05, ** P,0.01.
(DOCX)
Table S3 Densitometry measurement of COMP m/m
CHOP +/+ and CHOP 2/2 Western blots at 3 weeks
(n=4, t-test). Standard error of the mean. Key: +/+ wild type,
2/2 knockout (null), m/m homozygous mutant. * P,0.05.
(DOCX)
Table S4 Raw data for BrdU analysis and TUNEL
analysis included in the paper (n=3, One Way ANOVA).
Standard error of the mean. Key: RZ resting zone, PZ
proliferative zone, HZ hypertrophic zone, +/+ wild type, 2/2
knockout (null), m/m homozygous mutant. * P,0.05, ** P,0.01,
*** P,0.001.
(DOCX)
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